Newsroom

ILC Therapeutics’ COO Dawn Firmin spoke with Manufacturing Chemist on the challenges in developing a novel drug class, and the Company’s journey so far and how it addressed some of these key challenges.

As we live through the most rapidly evolving viral environment the world has seen, there is a critical need for effective and safe antiviral medicines to meet the challenges of today and the inevitable threats of tomorrow. Worldwide, we are

An interview with Founder & Chief Scientific Officer William Stimson in Drug Discovery World.